Liang Yuyu1, Zhu Rongrong2, Yang Yong2, and Zhuo Zhizheng3
1Imaging, NingXia People's Hospital, Yinchuan, China, 2Imaging, NingXia People's Hospital, YinChuan, China, 3Imaging Systemt Clinical Science Philips Healthcare, Philips(China) Investment co.Ltd., Beijing, China
Synopsis
This study aims to
explore the efficacy of NAC assessed by quantitative multi-parameter utilized
bi-exponential diffusion weighted imaging in breast cancer. In this study,
there is significant difference in ΔFfast value between groups,
mainly results from the rise of Ffast value of tumor
because of chemotherapy. Nonetheless, the diagnosis efficacy is mild for NAC
assessment using ΔFfast value.
Introduction
Neoadjuvant chemotherapy (NAC) is the standard
therapy method before operation[1]. Therefore, evaluation of treatment of
chemotherapy is the key point in clinical. This study mainly investigates the
efficacy of NAC assessed by quantitative multi-parameter utilized
bi-exponential diffusion weighted imaging in breast cancer. Methods
55 subjects with breast carcinoma were recruited. This
study was approved by the Ethics Committee of Ningxia People’s Hospital, Yinchuan,China. These patients underwent the MR scanning by
using a 3T scanner (Ingenia,Philips Healthcare, Best, The Netherlands) with an
IVIM protocol: (TR=1000ms,TE=76.5 ms,slice thickness=5mm,slice space=1.5mm,10 b values of b=0, 20, 30, 50 100, 200, 400, 800, 1000,
1500s/mm2. The IVIM images were preprocessed by a bi-exponential
model before NAC and after 2 NAC episodes, respectively. The value of slow
apparent diffusion coefficient (ADC), fast ADC and Ffast were measured.
These patients were divided into effective group and ineffective group
according to the criteria of treatment evaluation in solid tumor. Paired
student’s t test was applied to
compare the slow ADC, fast ADC, Ffast in two groups. The slow ADC,
fast ADC, Ffast, Δslow ADC and ΔFfast calculated as the
value difference before and after NAC were compared by independent student’s t test; p < 0.05 was considered statistically significant. A
receiver-operating characteristic (ROC) analysis was performed to evaluate the
sensitivity and specificity of NAC efficacy in two groups with ΔFfast.Results
32 subjects were classified as effective group and
23 subjects for ineffective group. Before
and after NAC, the slow ADC was
(0.397 ±0.219) * 10-3 and (0.672 ± 0.321) * 10-3 mm2/s
in effective group respectively, and these values were (0.336 ± 0.090) * 10-3
and (0.622 ± 0.243) * 10-3mm2/s in ineffective group
respectively, there is significant difference in slow
ADC between effective and ineffective groups before and after-NAC. However,
there is no significant difference was found in intra-group. Before and
after NAC, the fast ADC was (7.139 ± 2.495) * 10-3 and (7.696 ±
3.683) * 10-3mm2/s in effective group respectively, and
these values were (8.447 ± 4.137) * 10-3 and (8.741 ± 5.160) * 10-3mm2/s
in the ineffective group respectively. There is no significant difference in
fast ADC before or after NAC between two groups. Before and after NAC, the Ffast was 0.319 ± 0.0.142 and 0.576 ± 0.133
in effective group respectively, and these values were 0.359 ± 0.130 and 0.52 ±
0.14 in ineffective group respectively. there is significant difference in Ffast
between effective and ineffective groups before and after-NAC, but, there is no
significant difference was found in intra-group. The
AUC (area under curve) was 0.700 in the ΔFfast ROC. When 0.136 was
set as the cut-off value, sensitivity and specificity was 81.3% and 60.9%
respectively, the assessment efficacy was moderate.Discussion
Cell necrosis post-neoadjuvant chemotherapy (NAC),
enlargement of extracellular space and the increase of interstitial substance
such as vessel, that reflect the rise of Ffast value (perfusion
factor stands for the organization microcirculation) [2], especially for the tumor cell which is sensitive to chemotherapy.Conclusion
The slow
ADC and Ffast were increased prominently measured by multi-b bi-exponential
model DWI before and after NAC.
However, there is no significant advantage of ΔFfast to evaluate the
treatment efficacy in NAC in breast carcinoma.Acknowledgements
No acknowledgement found.References
1 Hylton N. MR imaging for assessment of breast
cancer response to neoadjuvant chemotherapy[J]. Magn Reson Imaging Clin N Am,
2006, 14(3):383-389.
2 Tamura T,Usui S,Murakami S,et al.Comparisons of
multi b-value DWI signal analysis with pathological specimen of breast
cancer[J].Magn Reson Med,2012,68:890-897.